<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01315652</url>
  </required_header>
  <id_info>
    <org_study_id>P100113</org_study_id>
    <secondary_id>P140101</secondary_id>
    <nct_id>NCT01315652</nct_id>
  </id_info>
  <brief_title>Interest of a Standardized Monitoring of Rheumatoid Arthritis: The COMEDRA Trial</brief_title>
  <acronym>COMEDRA</acronym>
  <official_title>Evaluation of the Usefulness of a Center Specialized in the Standardized Management of Rheumatoid Arthritis: The COMEDRA Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>French Society of Rheumatology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Roche Chugai</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The two objectives of this trial are :1 To evaluate the impact of a visit with a nurse
      checking the preventive modalities and/or the presence of comorbidities such as infections (
      e.g. vaccinations), cardiovascular-diseases (e.g. Indication to statin,
      antiaggregant,anti-hypertensive treatment…), cancers (e.g.mammography,…), osteoporosis (e.g.
      bone densitometry,..) in patients suffering from Rheumatoid Arthritis 2 To evaluate the
      impact of an educational program aimed at permitting rheumatoid arthritis patients to
      auto-evaluate their disease activity by collecting the Disease Activity Score (DAS28-ESR).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with a stable definite Rheumatoid Arthritis will be invited by their rheumatologists
      to participate at this study in 20 centers in France. After written informed consent will be
      obtained, the patients will be randomized in two arms:

        -  comorbidities

        -  auto-DAS The patients will be seen again in the same center six months later in order to
           collect the outcome measures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comorbidities treatment</measure>
    <time_frame>6 months later</time_frame>
    <description>Number of actions initiated I order to treat or prevent Rheumatoid Arthritis comorbidities</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Auto-DAS: Patient education to calculate his Disease Activity Score</measure>
    <time_frame>6 months after</time_frame>
    <description>Number of patients with a modification in their treatment between baseline and 6 months visits</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of comorbidities in Rheumatoid Arthritis</measure>
    <time_frame>6 months later</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adhesion to the current recommendations concerning the prevention of co-morbidities</measure>
    <time_frame>6 months later</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance and satisfaction of the patients concerning the DAS educational program</measure>
    <time_frame>6 months later</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">970</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Auto DAS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>&quot;Auto-DAS&quot;Number of patients with a modification in their treatment between baseline and 6 months visits</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comorbidities treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Comorbidities treatment</intervention_name>
    <description>&quot; Comorbidities treatment&quot;:Number of actions initiated in order to treat or prevent Rheumatoid Arthritis comorbidities during the 6 months follow-up</description>
    <arm_group_label>Comorbidities treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Auto-DAS</intervention_name>
    <description>&quot;Auto-DAS&quot;Number of patients with a modification in their treatment between baseline and 6 months visits</description>
    <arm_group_label>Auto DAS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Rheumatoid Arthritis

          -  Stable (no change in therapy)

          -  Adult

          -  Able to collaborate

        Exclusion criteria

          -  Pregnant woman

          -  Change of the therapy for 3 months before the inclusion

          -  Alcoholism, toxicomania, psychological problem, sever co morbidity which could invalid
             the consent or limit the protocol compliance

          -  No social coverage affiliate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maxime Dougados, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2011</study_first_submitted>
  <study_first_submitted_qc>March 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2011</study_first_posted>
  <last_update_submitted>July 5, 2016</last_update_submitted>
  <last_update_submitted_qc>July 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>1 Rheumatoid arthritis</keyword>
  <keyword>2 Education</keyword>
  <keyword>3 Co-morbidities</keyword>
  <keyword>4 Nurse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

